Credit Suisse’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Credit Suisse’s Portfolio NITE Stock Details NITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-63,800	Closed	-$1.62M	–	4327
2019 Q1	$1.62M	Buy	+63,800	New	+$1.13M	﹤0.01%	2526

Credit Suisse's NITE Position: Q2 2019 in Review

Credit Suisse sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q2 2019, closing a stake of 63,800 shares — an estimated $1.62M sold.

Credit Suisse first reported a position in NITE in Q1 2019 and held it in 1 quarter. The position peaked at $1.62M in Q1 2019. 0 funds tracked by Wall St. Rank hold NITE as of Q2 2019.

Credit Suisse reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
Credit Suisse sold 63,800 Nightstar Therapeutics plc American Depositary Shares shares in Q2 2019, an estimated $1.62M.
Credit Suisse first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q1 2019 and held it in 1 quarter.
Credit Suisse's Nightstar Therapeutics plc American Depositary Shares position peaked at $1.62M in Q1 2019.
0 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q2 2019.

Based on Credit Suisse's 13F filing for Q2 2019, filed 14 Aug 2019.